Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Favorable Outcomes with Bridging Radiation Therapy Prior to Anti-CD19 Chimeric Antigen Receptor T-Cell CART in B Cell Lymphoma, a Report from Saudi Arabia

Blood (2024) 144 (Supplement 1): 7754.

https://doi.org/10.1182/blood-2024-202399

Published: 2024

Journal Articles

Prognostic Impact of CD19 Status Pre-Lymphodepletion in Anti-CD19 CAR-T Therapy for B-Acute Lymphoblastic Leukemia

Blood (2024) 144 (Supplement 1): 7153.

https://doi.org/10.1182/blood-2024-207988

Published: 2024

Journal Articles

Non-Western Real-World Experience of Axi-Cel CAR-T in Refractory/Relapsed B-Cell Lymphoma from a Tertiary Center in Saudi Arabia

Blood (2024) 144 (Supplement 1): 7824.

https://doi.org/10.1182/blood-2024-203769

Published: 2024

Journal Articles

First Description of New Variant of Germline ERCC6L2 Mutations Causing Bone Marrow Failure, a Single Center Report of 11 Cases in 7 Families

Alfadil Haroon, Abdullah Aljefri, Mohamed Jaradi, Ahmad S. Alotaibi, Mansour Alfayez, Hazza Alzahrani, Fahad Almohareb, Ali D Alahmari, Ayman Saad, Walid Rasheed, Fahad Z. Alsharif, Naeem A. Chaudhri, Haitham A. Khogeer, Abdullah Alsuwaidan, Mahmoud Aljurf, Syed Osman Ahmed

Blood (2024) 144 (Supplement 1): 5706.

https://doi.org/10.1182/blood-2024-193282

Published: 2024

Journal Articles

Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Patients Receiving Inotuzumab Ozogamicin Followed By Total Body Irradiation-Based Conditioning for Stem Cell Transplantation: A Risk Mitigation Strategy

Ahmed Alahmadi, Abdulrahman Nasiri, Sarah Samarkandi, Haya Alothaimeen, Marwa Nassar, Ali Alahmari, Ahmad S. Alotaibi, Mansour Alfayez, Hanan Alkhaldi, Ayman Saad, Syed Osman Ahmed, Amr Hanbali

Blood (2024) 144 (Supplement 1): 7306.

https://doi.org/10.1182/blood-2024-200803

Published: 2024

Journal Articles

Evaluating the Safety and Efficacy of Tyrosine Kinase Inhibitors in Pregnant Patients with Chronic Myeloid Leukemia: A Comprehensive 15-Year Single-Center Study

Blood (2024) 144 (Supplement 1): 4536.

https://doi.org/10.1182/blood-2024-207937

Published: 2024

Journal Articles

Single-Cell Polyfunctional Proteomic Profiling Reveals Temporal and Niche Differences in CD4 and CD8 T Cells in Acute Myeloid Leukemia Following PD-1 Blockade Therapy

Jessica Lynn Root, Poonam N Desai, Patrick K Reville, Christopher Ly, Bofei Wang, Fatima Z Jelloul, Jing Zhou, Sean Gregory Mackay, Mansour Alfayez, Jairo Matthews, Sherry Pierce, Naval Daver, Hussein A Abbas

Blood (2023) 142 (Supplement 1): 1584.

https://doi.org/10.1182/blood-2023-188268

Published: 2023

Journal Articles

Superior Outcome of Bone Marrow Transplantation Using Fludarabine and Cyclophosphamide with ATG over Fludarabine and Cyclophosphamide without ATG Conditioning Regimen in Severe Aplastic Anemia

Blood (2023) 142 (Supplement 1): 6951.

https://doi.org/10.1182/blood-2023-182333

Published: 2023

Journal Articles

Allogeneic Stem Cell Transplantation in Adolescent and Adult Patients with Acute T Cell Lymphoblastic Leukemia / Lymphoma : Single Center Experience of 143 Patients

Blood (2023) 142 (Supplement 1): 7101.

https://doi.org/10.1182/blood-2023-185676

Published: 2023

Journal Articles

Blinatumomab with Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review

Blood (2023) 142 (Supplement 1): 5889.

https://doi.org/10.1182/blood-2023-180221

Published: 2023

Journal Articles

Molecular Characterisation and Outcomes of 363 Adolescent and Young Adults with AML in Saudi Arabia Risk Stratified By PCR and NGS-Based Testing

Blood (2023) 142 (Supplement 1): 7433.

https://doi.org/10.1182/blood-2023-187940

Published: 2023

Journal Articles

Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment-Free Remission in Chronic-Phase Chronic Myeloid Leukemia: An Observational Retrospective Multi-Center Study

Aamer Aleem, Farjah Alqahtani, Ahmed Jamal, Nora A. Alkhudair, Mashail Alghafis, Hajar Wan Zuki Siti, Bader Alahmari, Hend Salama, Giamal Edin Gmati, Mohsen Alzahrani, Ayman Alhejazi, Naila A. Shaheen, Abdullah M Alrajhi, Mansour Alfayez, Zafar Iqbal, Ahmed Alaskar

Blood (2022) 140 (Supplement 1): 12220–12221.

https://doi.org/10.1182/blood-2022-168926

Published: 2022

Journal Articles

Allogeneic Hematopoietic Cell Transplant Yields Long Term Disease Free Survival in a Significant Number of Patients with Classic Hodgkin Lymphoma

Blood (2022) 140 (Supplement 1): 12969–12970.

https://doi.org/10.1182/blood-2022-164820

Published: 2022

Journal Articles

Conventional Versus Condensed Regimen of High Dose Cytarabine Consolidation in Acute Myeloid Leukemia

Abdullah M Alrajhi, Jude Howaidi, Adel Alnakhli, Fouad H. Alnajjar, Mansour Alfayez

Blood (2022) 140 (Supplement 1): 11729–11730.

https://doi.org/10.1182/blood-2022-166355

Published: 2022

Journal Articles

Venetoclax Treatment Outcomes and Patterns of Use in Relapsed/Refractory Chronic Lymphocytic Leukemia Under Routine Clinical Practice in Saudi Arabia and Gulf Countries (VICTORY Study)

Tarek Abouzeid, Taimoor Hussain, Sameer AlAmoudi, Ahmad Absi, Arif Alam, Mansour Alfayez, Ahmad Alhuraiji, Mohammed Aldarweesh, Husni Al-Hateeti, Gehad El Ashal, Omar Hussein, Ali Anwar, Mohamed Gouda Ismail, Leila Bereksi, Haidy Abdellatif, Yasser Nour, Abdallah Saad, Naeem A. Chaudhri

Blood (2022) 140 (Supplement 1): 12397–12399.

https://doi.org/10.1182/blood-2022-168049

Published: 2022

Journal Articles

Utility and Validity of Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) in Predicting Overall Survival and Non-Relapse Mortality in Adolescent and Young Adult Population

Blood (2022) 140 (Supplement 1): 10566–10567.

https://doi.org/10.1182/blood-2022-167509

Published: 2022

Journal Articles

Polatuzumab Vedotin As a Salvage Treatment in Relapsed or Refractory DLBCL: Single Center Experience

Marwa Bin Morya, Mohammed A. Marei, Imran K. Tailor, Abdullah M Alrajhi, Adel Alnakhli, Foud Alnajjar, Mohammed S. Alnoamani, Hassan Alshehri, Ibraheem H. Motabi, Nawal AlShehry, Mansour Alfayez

Blood (2021) 138 (Supplement 1): 4558.

https://doi.org/10.1182/blood-2021-150242

Published: 2021

Journal Articles

Safety and Efficacy of Azacitidine with Venetoclax for Newly Diagnosed Intensive Chemotherapy Ineligible, and Relapsed or Refractory Acute Myeloid Leukemia in Arab Population: A Single-Center, Retrospective Study

Mohammmad Alwadi, Jude Howaidi, Abdullah M Alrajhi, Adel Alnakhli, Mohammed A. Marei, Imran K. Tailor, Fouad H. Alnajjar, Syed Y. Altaf, Mohammed S. Alnoamani, Kamal Alzahrani, Hassan Alshehri, Ibraheem H. Motabi, Syed Ziauddin A Zaidi, Nawal F Alshehry, Mansour Alfayez

Blood (2021) 138 (Supplement 1): 4423.

https://doi.org/10.1182/blood-2021-153335

Published: 2021

Journal Articles

JAK2 GGCC (46/1) Haplotype in Unprovoked Venous Thrombotic Events

Maged Al-Ammari, Abdul Ali Peer Zada, Ibraheem H. Motabi, Belal M. Albtoosh, Syed Y. Altaf, Imran K. Tailor, Mohammed S. Alnoamani, Syed Ziauddin A Zaidi, Mansour Alfayez, Nawal F Alshehry, Mohammed A. Marei

Blood (2021) 138 (Supplement 1): 4258.

https://doi.org/10.1182/blood-2021-149560

Published: 2021

Journal Articles

Efficacy of Brentuximab Vedotin and Bendamustine Combination in Relapsed/Refractory Hodgkin Lymphoma: Experience from a Tertiary Care Hospital

Abdullah M Alrajhi, Razan A. Aljalali, Lara H. Alghazi, Ibrahim Asiri, Adel Alnakhli, Fouad H. Alnajjar, Nawal F Alshehry, Ibraheem H. Motabi, Mohammed S. Alnoamani, Mohammed A. Marei, Mansour Alfayez, Imran K. Tailor

Blood (2021) 138 (Supplement 1): 4532.

https://doi.org/10.1182/blood-2021-152911

Published: 2021

NARROW

Favorable Outcomes with Bridging Radiation Therapy Prior to Anti-CD19 Chimeric Antigen Receptor T-Cell CART in B Cell Lymphoma, a Report from Saudi Arabia

Prognostic Impact of CD19 Status Pre-Lymphodepletion in Anti-CD19 CAR-T Therapy for B-Acute Lymphoblastic Leukemia

Non-Western Real-World Experience of Axi-Cel CAR-T in Refractory/Relapsed B-Cell Lymphoma from a Tertiary Center in Saudi Arabia

First Description of New Variant of Germline ERCC6L2 Mutations Causing Bone Marrow Failure, a Single Center Report of 11 Cases in 7 Families

Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Patients Receiving Inotuzumab Ozogamicin Followed By Total Body Irradiation-Based Conditioning for Stem Cell Transplantation: A Risk Mitigation Strategy

Evaluating the Safety and Efficacy of Tyrosine Kinase Inhibitors in Pregnant Patients with Chronic Myeloid Leukemia: A Comprehensive 15-Year Single-Center Study

Single-Cell Polyfunctional Proteomic Profiling Reveals Temporal and Niche Differences in CD4 and CD8 T Cells in Acute Myeloid Leukemia Following PD-1 Blockade Therapy

Superior Outcome of Bone Marrow Transplantation Using Fludarabine and Cyclophosphamide with ATG over Fludarabine and Cyclophosphamide without ATG Conditioning Regimen in Severe Aplastic Anemia

Allogeneic Stem Cell Transplantation in Adolescent and Adult Patients with Acute T Cell Lymphoblastic Leukemia / Lymphoma : Single Center Experience of 143 Patients

Blinatumomab with Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review

Molecular Characterisation and Outcomes of 363 Adolescent and Young Adults with AML in Saudi Arabia Risk Stratified By PCR and NGS-Based Testing

Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment-Free Remission in Chronic-Phase Chronic Myeloid Leukemia: An Observational Retrospective Multi-Center Study

Allogeneic Hematopoietic Cell Transplant Yields Long Term Disease Free Survival in a Significant Number of Patients with Classic Hodgkin Lymphoma

Conventional Versus Condensed Regimen of High Dose Cytarabine Consolidation in Acute Myeloid Leukemia

Venetoclax Treatment Outcomes and Patterns of Use in Relapsed/Refractory Chronic Lymphocytic Leukemia Under Routine Clinical Practice in Saudi Arabia and Gulf Countries (VICTORY Study)

Utility and Validity of Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) in Predicting Overall Survival and Non-Relapse Mortality in Adolescent and Young Adult Population

Polatuzumab Vedotin As a Salvage Treatment in Relapsed or Refractory DLBCL: Single Center Experience

Safety and Efficacy of Azacitidine with Venetoclax for Newly Diagnosed Intensive Chemotherapy Ineligible, and Relapsed or Refractory Acute Myeloid Leukemia in Arab Population: A Single-Center, Retrospective Study

JAK2 GGCC (46/1) Haplotype in Unprovoked Venous Thrombotic Events

Efficacy of Brentuximab Vedotin and Bendamustine Combination in Relapsed/Refractory Hodgkin Lymphoma: Experience from a Tertiary Care Hospital

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only